FDA clears Pfizer drug for advanced kidney cancer
January 27, 2012 in Medications(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
The Food and Drug Administration approved the company's drug Axitinib as a secondary option for patients with renal cell carcinoma, which starts in the lining of small tubes found in the kidney. Renal cell carcinoma is the most common form of kidney cancer, with an estimated 61,000 people in the U.S. newly diagnosed last year, according to the National Cancer Institute. Only about 11 percent of patients with advanced kidney cancer survive five years or more after diagnosis.
Like several other recent cancer drugs, Axitinib works by blocking proteins that promote tumor growth and cancer progression.
©2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
FDA panel backs Pfizer drug for kidney cancer
Dec 07, 2011 |
not rated yet |
0
-
FDA approves new drug for deadly kidney cancer
Mar 30, 2009 |
not rated yet |
0
-
Experimental drug shows promise in advanced kidney cancer
Sep 26, 2007 |
not rated yet |
0
-
Cancer-seeking 'smart bombs' target kidney cancer cells
Jun 06, 2011 |
not rated yet |
0
-
EU approves Avastin for lung cancer
Aug 24, 2007 |
not rated yet |
0
-
Remembrance of things future: Long-term memory sets the stage for visual perception
Dec 28, 2011 |
3.6 / 5 (13) |
4
-
Beyond brain scanning: Simultaneous high-resolution 3D neural imaging and photostimulation
Nov 28, 2011 |
5 / 5 (8) |
2
-
The error-correcting brain: New insights into the neurobiology of adaptive behavior
Oct 27, 2011 |
4.9 / 5 (10) |
6
-
The brain on drugs: Defining the neural anatomy and physiology of morphine on dopamine neurons
Oct 04, 2011 |
4.8 / 5 (4) |
1
-
Now see this: Anti-inflammatory treatment reverses stroke-induced compromise in sensory learning
Sep 22, 2011 |
4 / 5 (9) |
2
-
stomach not emptying
Feb 16, 2012
-
White reflections in photos in one eye
Feb 15, 2012
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
- More from Physics Forums - Medical Sciences
More news stories
FDA panel backs previously rejected obesity pill
(AP) -- A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill called Qnexa, a drug which the FDA previously rejected due to safety concerns.
Medications
7 hours ago |
not rated yet |
0
Study: No significant rise in seizure risk from common kids' vaccine
(HealthDay) -- Children who receive a combination vaccine known as DTaP-IPV-Hib have no significant increased risk of febrile seizure, a convulsion triggered by a fever, during the week after vaccination, ...
Medications
7 hours ago |
not rated yet |
0
|
Lessons from $800-million drug flop may lead to a new genre of anti-cholesterol medicines
Mindful of lessons from a failed heart drug that cost $800 million to develop, drug companies are taking another shot at new medications that boost levels of so-called "good cholesterol," which removes cholesterol from the ...
Medications
11 hours ago |
not rated yet |
0
Fake drug sales are increasing on the Internet and turning up in legitimate supply chains
Criminal gangs are increasingly using the internet to market life-threatening counterfeit medicines and some have even turned up in legitimate outlets such as pharmacies, according to a review led by Dr Graham Jackson, editor ...
Medications
12 hours ago |
not rated yet |
0
FDA: New suppliers to ease 2 cancer drug shortages
Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about missing life-saving treatments.
Medications
Feb 21, 2012 |
not rated yet |
0
CT colonography shown to be comparable to standard colonoscopy
Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according ...
Study: Virtual colonoscopy effective screening tool for adults over 65
Computed tomography (CT) colonography can be used as a primary screening tool for colorectal cancer in adults over the age of 65, according to a new study published online in the journal Radiology.
Mini molecules could help fight battle of aortic bulge
When aortic walls buckle, the body's main blood pipe forms an ever-growing bulge. To thwart a deadly rupture, a team of Stanford University School of Medicine researchers has found two tiny molecules that may be able to orchestrate ...
Research links circadian rhythms to sudden cardiac death
A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body's natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or abn ...
Analysis of mTOR shows how the protein works, how new generation of drugs may defeat it
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered ...
Phobia's effect on perception of feared object allows fear to persist
The more afraid a person is of a spider, the bigger that individual perceives the spider to be, new research suggests.
